Bulletin from the Extraordinary General Meeting 2023 of Cell Impact AB (publ)
The extraordinary general meeting of Cell Impact AB (publ) was held on 3 November 2023.
Resolution regarding amendments to the articles of association
The general meeting resolved in accordance with the board’s two proposals on amendments to 4-5 §§ of the articles of association, entailing:
partly that the articles of association shall be amended so that the share capital shall be not less than SEK 23,151,250 and not more than SEK 92,605,000, and that the number of shares shall be not less than 200,000,000 and not more than 800,000,000,
partly that the articles of association shall be amended so that the share capital shall be not less than SEK 46,302,500 and not more than SEK 185,210,000, and that the number of shares shall be not less than 400,000,000 and not more than 1,600,000,000.
Further, the general meeting resolved to authorize the board of directors to submit for registration with the Swedish Companies Registration Office, the one of the abovementioned resolutions regarding amendments to the articles of association which limits for the minimum and maximum number of shares in the company are compatible with the total number of shares in the company following the board of directors’ resolution on a new issue on the basis of the issue authorization set forth below.
Resolution regarding issue authorization
The general meeting resolved in accordance with the board’s proposal to authorize the board of directors to, on one or more occasions, during the period until the next annual general meeting, resolve on issues of new shares, warrants and/or convertibles, with preferential rights for the company’s existing shareholders. The company’s share capital and number of shares may, by virtue of the authorization, be increased with an amount and number that falls within the limits of the, at any time registered, or by the general meeting adopted, articles of association.
Complete proposals regarding the resolutions by the extraordinary general meeting in accordance with the above are available at Cell Impact’s website, www.cellimpact.com.